End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion

被引：13

作者：

Bifulco, Maurizio ^{[1
]}

Pisanti, Simona ^{[1
]}

机构：

[1] Univ Salerno, Dept Pharmaceut Sci, Salerno, Italy

来源：

NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 07期

关键词：

D O I：

10.1038/nrd2775-c1

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

[No abstract available]

引用

收藏

页码：594 / 594

页数：1

相关论文

共 6 条

[1]

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) [J].

Barrero, FJ ;

Ampuero, I ;

Morales, B ;

Vives, F ;

del Castillo, JDL ;

Hoenicka, J ;

Yébenes, JG .

PHARMACOGENOMICS JOURNAL, 2005, 5 (02) :135-141

[2]

Overweight, obesity, and cancer risk [J].

Bianchini, F ;

Kaaks, R ;

Vainio, H .

LANCET ONCOLOGY, 2002, 3 (09) :565-574

[3]

Endocannabinoids in endocrine and related tumours [J].

Bifulco, Maurizio ;

Malfitano, Anna Maria ;

Pisanti, Simona ;

Laezza, Chiara .

ENDOCRINE-RELATED CANCER, 2008, 15 (02) :391-408

[4]

Rimonabant: Just an Antiobesity drug? Current evidence on its pleiotropic effects [J].

Bifulco, Maurizio ;

Grimaldi, Claudia ;

Gazzerro, Patrizia ;

Pisanti, Simona ;

Santoro, Antonietta .

MOLECULAR PHARMACOLOGY, 2007, 71 (06) :1445-1456

[5]

End of the line for cannabinoid receptor 1 as an anti-obesity target? [J].

Jones, Dan .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :961-962

[6]

Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy [J].

Pisanti, Simona ;

Borselli, Cristina ;

Oliviero, Olimpia ;

Laezza, Chiara ;

Gazzerro, Patrizia ;

Bifulco, Mauriz .

JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (02) :495-503